Efficacy News and Research

RSS
Researchers investigate Moderna COVID-19 vaccine efficacy

Researchers investigate Moderna COVID-19 vaccine efficacy

SARS-CoV-2 Delta variant mutation sites

SARS-CoV-2 Delta variant mutation sites

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Breakthrough infections from SARS-CoV-2 Delta variant among vaccinated healthcare workers

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

Serum SARS-CoV-2 antigen: A better predictor of COVID-19 severity

New, improved organoids shed light on untreatable form of prostate cancer

New, improved organoids shed light on untreatable form of prostate cancer

Treatment with antihistamines associated with improved responses to immunotherapy

Treatment with antihistamines associated with improved responses to immunotherapy

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

CIRM awards $4.1 million to advance CAR T-cell therapy from the lab to clinic

Common heart burn medication could lessen the effectiveness of lung cancer treatment

Common heart burn medication could lessen the effectiveness of lung cancer treatment

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Higher antibody level correlates with greater vaccine protection against COVID-19

Higher antibody level correlates with greater vaccine protection against COVID-19

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Mouthwash containing an antiviral phthalocyanine derivative shortens hospitalizations due to COVID-19

Anti-inflammatory drug used to treat gout does not reduce the risk of COVID-19 mortality

Anti-inflammatory drug used to treat gout does not reduce the risk of COVID-19 mortality

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

Oral Hsp90 inhibitor SNX-5422 interferes with replication machinery of SARS-CoV-2

LSHTM joins with YouTube and Klick Health to create 'Community Unity' for tackling vaccine misinformation

LSHTM joins with YouTube and Klick Health to create 'Community Unity' for tackling vaccine misinformation

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

Systematic review finds COVID-19 vaccine efficacy remains high for at least six months

Systematic review finds COVID-19 vaccine efficacy remains high for at least six months

An increase in the half-life of remdesivir for COVID-19 treatment

An increase in the half-life of remdesivir for COVID-19 treatment

What does the future look like for bleeding disorders?

What does the future look like for bleeding disorders?

Novel Lyme disease vaccine may also combat other tick-borne diseases

Novel Lyme disease vaccine may also combat other tick-borne diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.